Please note that masks must still be worn within NYOH practices regardless of vaccination status.
Learn more about this and other COVID-19 related updates

About Us

NYOH plays role in new drug test to detect cancer

9/09/2020

Amy Zuchelkowski, Director of Research Operations, talks with WNYT's Benita Zahn about a new clinical trial that tests for 50 cancers. NYOH participated in a trial that was a precursor to Pathfinder, with Dr. Lawrence Garbo as Principal Investigator. 

NYOH offers the region's largest clinical research operation, participating in more than 500 drug trials over the past 40 years -- leading to 50 new FDA-approved cancer treatments. Search open trials by cancer type or learn more about the advantages of participating in a clinical trial.